Eli Lilly Defeats Soldier's Cymbalta 'Brain Zap' Suit

Law360, New York (December 17, 2013, 4:21 PM EST) -- A South Carolina federal judge ruled Monday that Eli Lilly & Co. did not fail to adequately warn an Iraq War veteran that the antidepressant Cymbalta can cause so-called brain zaps and other withdrawal symptoms, finding that a stronger warning would not have altered his treatment.

U.S. District Judge Cameron McGowan Currie granted summary judgment to Eli Lilly in a lawsuit brought by plaintiff Scott Carnes, who claimed he suffered "sharp, painful zaps of electricity" in his head, nightmares and anger issues after quitting Cymbalta, and still "shakes ... like a dog getting wet" as the result of his use of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login